Provider
Self Administered Oncology Agents - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Search Results
Displaying 1991 - 2000 of 3661 results
Provider
Rayos® (prednisone delayed-release tablet) - Commercial
Prior Authorization
Program effective Date: Jan 01, 2025
Provider
Oxybate - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
QP9-22 Timely Filing Denials for COVID-19 Testing and Immunizations
Program effective Date: Feb 09, 2022
Provider
QP10-22 Commercial Pharmacy Benefit Exclusion for Basaglar®
Program effective Date: Feb 09, 2022
Provider
QP11-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2022
Program effective Date: Feb 09, 2022
Provider
Topical Lidocaine - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025
Provider
Topical Doxepin - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025
Provider
Topical Doxepin - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025
Provider
P7-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Program effective Date: Feb 01, 2022